Your browser doesn't support javascript.
loading
Cost-Effectiveness Analysis of Sunitinib versus Interferon-Alfa for First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma in Singapore.
Pruis, Sil-Ling; Aziz, Mohamed Ismail Abdul; Pearce, Fiona; Tan, Min Han; Wu, David Bin-Chia; Ng, Kwong.
  • Pruis SL; Agency for Care Effectiveness,Ministry of Health,Singapore.
  • Aziz MIA; Agency for Care Effectiveness,Ministry of Health,Singapore.
  • Pearce F; Agency for Care Effectiveness,Ministry of Health,Singapore.
  • Tan MH; Division of Medical Oncology Singapore,Singapore.
  • Wu DB; Agency for Care Effectiveness,Ministry of Health,Singapore.
  • Ng K; Agency for Care Effectiveness,Ministry of Health,Singapore.
Int J Technol Assess Health Care ; 35(2): 126-133, 2019 Jan.
Article en En | MEDLINE | ID: mdl-30854989
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Interferón-alfa / Sunitinib / Neoplasias Renales / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Interferón-alfa / Sunitinib / Neoplasias Renales / Antineoplásicos Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article